Cerulean Pharma appoints new board member
This article was originally published in Scrip
Cerulean Pharma has named Stuart A Arbuckle to its board of directors, effective 26 June. Mr Arbuckle is currently executive vice president and chief commercial officer at Vertex Pharmaceuticals where he oversees Vertex's global commercial team. Prior to joining Vertex, Mr Arbuckle held multiple commercial leadership roles at Amgen, including vice-president and general manager, oncology business unit.
You may also be interested in...
A complete response letter from the FDA in June knocked Intercept’s stock price down to 2014 levels, but perhaps the regulator is sending wider messages about NASH.
A selection of features you might have missed from the first six months of 2020, covering key topics from COVID-19 strategies in medtech to an analysis of pipeline focus areas across the pharma sector. Click on each section to get the full story behind the data.
The two-part vaccine becomes the second against Ebola to get approval. Janssen is now collaborating with the World Health Organization on vaccine pre-qualification to get it to people in need.